Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL)

Citation

• Tarighat, S. S., Fei, F., Bum-Erdene, K., Blanchard, H., Groffen, J., & Heisterkamp, N. (2015). Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL). BLOOD, 126(23), 3 pages. Retrieved from http://gateway.webofknowledge.com/

Web Of Science Accession Number

• WOS:000368020100212

Number Of Pages

• 3

Volume

• 126

Issue

• 23

Abstract

UOW Authors

•   Blanchard, Helen (external author)

Publication Date

• 2015

Publisher

• AMER SOC HEMATOLOGY 

Published In

• BLOOD  Journal

Citation

• Tarighat, S. S., Fei, F., Bum-Erdene, K., Blanchard, H., Groffen, J., & Heisterkamp, N. (2015). Galectin-3 Inhibition As a Novel Therapeutic Approach in Acute Lymphoblastic Leukemia (ALL). BLOOD, 126(23), 3 pages. Retrieved from http://gateway.webofknowledge.com/

Web Of Science Accession Number

• WOS:000368020100212

Number Of Pages

• 3

Volume

• 126

Issue

• 23